Similar articles for PMID: 27230924

Year	Number of Results
2003	1
2005	1
2006	1
2008	1
2009	1
2010	1
2011	3
2012	6
2013	14
2014	17
2015	25
2016	26
2017	35
2018	37
2019	37
2020	29
2021	21
2022	18
2023	8
2024	0

1

Quantitative Assessment of Breast Parenchymal Uptake on 18F-FDG PET/CT: Correlation with Age, Background Parenchymal Enhancement, and Amount of Fibroglandular Tissue on MRI.

Leithner D, Baltzer PA, Magometschnigg HF, Wengert GJ, Karanikas G, Helbich TH, Weber M, Wadsak W, Pinker K. Leithner D, et al. J Nucl Med. 2016 Oct;57(10):1518-1522. doi: 10.2967/jnumed.116.174904. Epub 2016 May 26. J Nucl Med. 2016. PMID: 27230924 Free article. Clinical Trial.

2

Preliminary analysis: Background parenchymal 18F-FDG uptake in breast cancer patients appears to correlate with background parenchymal enhancement and to vary by distance from the index cancer.

Kim E, Mema E, Axelrod D, Sigmund E, Kim SG, Babb J, Melsaether AN. Kim E, et al. Eur J Radiol. 2019 Jan;110:163-168. doi: 10.1016/j.ejrad.2018.11.031. Epub 2018 Nov 28. Eur J Radiol. 2019. PMID: 30599855 Free PMC article.

3

Multiparametric ¹⁸F-FDG PET/MRI of the Breast: Are There Differences in Imaging Biomarkers of Contralateral Healthy Tissue Between Patients With and Without Breast Cancer?

Leithner D, Helbich TH, Bernard-Davila B, Marino MA, Avendano D, Martinez DF, Jochelson MS, Kapetas P, Baltzer PAT, Haug A, Hacker M, Tanyildizi Y, Morris EA, Pinker K. Leithner D, et al. J Nucl Med. 2020 Jan;61(1):20-25. doi: 10.2967/jnumed.119.230003. Epub 2019 Jun 28. J Nucl Med. 2020. PMID: 31253745 Free PMC article.

4

Does breast MRI background parenchymal enhancement indicate metabolic activity? Qualitative and 3D quantitative computer imaging analysis.

Mema E, Mango VL, Guo X, Karcich J, Yeh R, Wynn RT, Zhao B, Ha RS. Mema E, et al. J Magn Reson Imaging. 2018 Mar;47(3):753-759. doi: 10.1002/jmri.25798. Epub 2017 Jun 24. J Magn Reson Imaging. 2018. PMID: 28646614

5

A multiparametric [¹⁸F]FDG PET/MRI diagnostic model including imaging biomarkers of the tumor and contralateral healthy breast tissue aids breast cancer diagnosis.

Leithner D, Horvat JV, Bernard-Davila B, Helbich TH, Ochoa-Albiztegui RE, Martinez DF, Zhang M, Thakur SB, Wengert GJ, Staudenherz A, Jochelson MS, Morris EA, Baltzer PAT, Clauser P, Kapetas P, Pinker K. Leithner D, et al. Eur J Nucl Med Mol Imaging. 2019 Aug;46(9):1878-1888. doi: 10.1007/s00259-019-04331-6. Epub 2019 Jun 13. Eur J Nucl Med Mol Imaging. 2019. PMID: 31197455 Free PMC article. Clinical Trial.

6

Histopathologic characteristics of background parenchymal enhancement (BPE) on breast MRI.

Sung JS, Corben AD, Brooks JD, Edelweiss M, Keating DM, Lin C, Morris EA, Patel P, Robson M, Woods M, Bernstein JL, Pike MC. Sung JS, et al. Breast Cancer Res Treat. 2018 Nov;172(2):487-496. doi: 10.1007/s10549-018-4916-6. Epub 2018 Aug 23. Breast Cancer Res Treat. 2018. PMID: 30140962 Free PMC article.

7

Metabolic changes in breast cancer on dual-time-point ¹⁸F-FDG PET/CT imaging according to primary tumor uptake and background parenchymal enhancement.

Kim HO, Kim BS, Kang SY, Bang JI, An J, Kim JH, Yoon HJ. Kim HO, et al. Ann Nucl Med. 2020 Dec;34(12):942-951. doi: 10.1007/s12149-020-01525-z. Epub 2020 Sep 24. Ann Nucl Med. 2020. PMID: 32974848

8

MRI Background Parenchymal Enhancement Is Not Associated with Breast Cancer.

Bennani-Baiti B, Dietzel M, Baltzer PA. Bennani-Baiti B, et al. PLoS One. 2016 Jul 5;11(7):e0158573. doi: 10.1371/journal.pone.0158573. eCollection 2016. PLoS One. 2016. PMID: 27379395 Free PMC article.

9

Amount of fibroglandular tissue FGT and background parenchymal enhancement BPE in relation to breast cancer risk and false positives in a breast MRI screening program : A retrospective cohort study.

Vreemann S, Dalmis MU, Bult P, Karssemeijer N, Broeders MJM, Gubern-Mérida A, Mann RM. Vreemann S, et al. Eur Radiol. 2019 Sep;29(9):4678-4690. doi: 10.1007/s00330-019-06020-2. Epub 2019 Feb 22. Eur Radiol. 2019. PMID: 30796568 Free PMC article.

10

Background parenchymal enhancement and fibroglandular tissue on breast MRI in women with high genetic risk: Are changes before and after risk-reducing salpingo-oophorectomy associated with breast cancer risk?

Bermot C, Saint-Martin C, Malhaire C, Sebbag-Sfez D, Mouret-Fourme E, Carton M, Thibault FE. Bermot C, et al. Eur J Radiol. 2018 Dec;109:171-177. doi: 10.1016/j.ejrad.2018.10.030. Epub 2018 Nov 2. Eur J Radiol. 2018. PMID: 30527300

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

239 results

Results by year